Cargando…

减低剂量预处理异基因造血干细胞移植治疗儿童范可尼贫血四例临床观察

OBJECTIVE: To evaluate the efficiency and safety of low intensity conditional regimen for children with Fanconi anemia (FA) receiving allogenic hematopoietic stem cells transplantation (allo-HSCT). METHODS: Four patients diagnosed as Fanconi anemia were enrolled in this study. One patient received H...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342984/
https://www.ncbi.nlm.nih.gov/pubmed/29562469
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.03.011
_version_ 1783555657364930560
collection PubMed
description OBJECTIVE: To evaluate the efficiency and safety of low intensity conditional regimen for children with Fanconi anemia (FA) receiving allogenic hematopoietic stem cells transplantation (allo-HSCT). METHODS: Four patients diagnosed as Fanconi anemia were enrolled in this study. One patient received HLA-identical sibling donor hematopoietic stem cell transplantation, two patients underwent unrelated donor matched (UD) HSCT, and one patient received unrelated cord blood transplantation. The conditional regimen consisted of Busulfan with low dose of cyclophosphamide. RESULTS: All 4 cases succeeded in allo-HSCT. The median time for neutrophils engraftment was 11(9–15) day, median time to platelets (PLT) engraftment was 12 (8–28) day. One case occurred with grade I of aGVHD, 1 case with hemorrhagic cystitis. No patient happened with hepatic veno-occlusive disease (VOD). CONCLUSION: Low intensity of conditional regimen is efficient and safe which should be recommended for FA patients with HSCT.
format Online
Article
Text
id pubmed-7342984
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-73429842020-07-16 减低剂量预处理异基因造血干细胞移植治疗儿童范可尼贫血四例临床观察 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To evaluate the efficiency and safety of low intensity conditional regimen for children with Fanconi anemia (FA) receiving allogenic hematopoietic stem cells transplantation (allo-HSCT). METHODS: Four patients diagnosed as Fanconi anemia were enrolled in this study. One patient received HLA-identical sibling donor hematopoietic stem cell transplantation, two patients underwent unrelated donor matched (UD) HSCT, and one patient received unrelated cord blood transplantation. The conditional regimen consisted of Busulfan with low dose of cyclophosphamide. RESULTS: All 4 cases succeeded in allo-HSCT. The median time for neutrophils engraftment was 11(9–15) day, median time to platelets (PLT) engraftment was 12 (8–28) day. One case occurred with grade I of aGVHD, 1 case with hemorrhagic cystitis. No patient happened with hepatic veno-occlusive disease (VOD). CONCLUSION: Low intensity of conditional regimen is efficient and safe which should be recommended for FA patients with HSCT. Editorial office of Chinese Journal of Hematology 2018-03 /pmc/articles/PMC7342984/ /pubmed/29562469 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.03.011 Text en 2018年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 论著
减低剂量预处理异基因造血干细胞移植治疗儿童范可尼贫血四例临床观察
title 减低剂量预处理异基因造血干细胞移植治疗儿童范可尼贫血四例临床观察
title_full 减低剂量预处理异基因造血干细胞移植治疗儿童范可尼贫血四例临床观察
title_fullStr 减低剂量预处理异基因造血干细胞移植治疗儿童范可尼贫血四例临床观察
title_full_unstemmed 减低剂量预处理异基因造血干细胞移植治疗儿童范可尼贫血四例临床观察
title_short 减低剂量预处理异基因造血干细胞移植治疗儿童范可尼贫血四例临床观察
title_sort 减低剂量预处理异基因造血干细胞移植治疗儿童范可尼贫血四例临床观察
topic 论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342984/
https://www.ncbi.nlm.nih.gov/pubmed/29562469
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.03.011
work_keys_str_mv AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá
AT jiǎndījìliàngyùchùlǐyìjīyīnzàoxuègànxìbāoyízhízhìliáoértóngfànkěnípínxuèsìlìlínchuángguānchá